Literature DB >> 2702730

Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.

L G Chi1, Y Tamura, P T Hoff, M Macha, K P Gallagher, M A Schork, B R Lucchesi.   

Abstract

Available data demonstrate that oxygen free radicals and derived reactive species of oxygen are produced during myocardial ischemia as well as upon reperfusion of the ischemic tissue. The present study was designed to determine if polyethylene glycol-conjugated superoxide dismutase (PEG-SOD), with its extended plasma half-life in excess of 30 hours in contrast to the native form of the enzyme (Native-SOD), could provide protection to the ischemic myocardium subjected to a 6-hour regional ischemia followed by reperfusion for 24 hours. We hypothesized that myocardial injury due to an ischemic interval is a dynamic process involving the sustained production of cytotoxic oxygen radicals that may continue beyond the ischemic interval. The ability to demonstrate a protective effect of the free radical scavenger enzyme superoxide dismutase would require the continued presence of the antioxidant during the ischemic interval and especially during reperfusion. To test this hypothesis, 22 anesthetized, open-chest dogs underwent 6 hours of circumflex coronary artery occlusion followed by reperfusion for 24 hours. Rapid administration of either Native-SOD (1,000 U/kg), PEG-SOD (1,000 U/kg), PEG-albumin (PEG-ALB), or 0.9% sodium chloride solution for injection (saline) was administered via the left atrium 15 minutes before occlusion of the vessel. A continuous infusion of an additional 1,000 U/kg of the respective enzyme interventions or an equivalent volume of PEG-ALB or saline was given during the 6-hour coronary artery occlusion and terminated 15 minutes after reperfusion. The animals were euthanized 24 hours after reperfusion, and the myocardial region at risk and the infarct region were quantitated by the tetrazolium method. The area of myocardium at risk of infarction, expressed as a percent of the left ventricle, did not differ among the groups: Native-SOD (n = 8), 46.2 +/- 1.8%; PEG-SOD (n = 6), 45.7 +/- 2.1%; PEG-ALB, 38.4 +/- 2.3% (n = 4); and saline 46.0 +/- 2.1% (n = 4). Hemodynamic parameters, the calculated rate-pressure-product, as well as regional myocardial blood flow (radiolabeled microsphere method) in the endocardial, midmyocardial, and epicardial segments of the risk and the nonrisk regions were comparable for all groups. Mean infarct size, determined 24 hours after reperfusion, in the group treated with PEG-SOD was 47.1 +/- 2.9% of the area at risk (n = 6), significantly smaller than that observed in each of the other treatment groups: Native-SOD, 63.5 +/- 2.2% (n = 8); PEG-ALB, 64.6 +/- 2.4% (n = 4); saline, 70.8 +/- 2.2% (n = 4).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702730     DOI: 10.1161/01.res.64.4.665

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

1.  Does Lethal Myocardial Reperfusion Injury Exist?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

Authors:  Gokulakrishnan Seshadri; Jay C Sy; Milton Brown; Sergey Dikalov; Stephen C Yang; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2009-11-03       Impact factor: 12.479

3.  Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury.

Authors:  Vishnu Undyala; Stanley R Terlecky; Richard S Vander Heide
Journal:  Cardiovasc Pathol       Date:  2010-08-12       Impact factor: 2.185

4.  Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.

Authors:  Gladys A Ngoh; Lewis J Watson; Heberty T Facundo; Steven P Jones
Journal:  Amino Acids       Date:  2010-08-27       Impact factor: 3.520

5.  The giant danio (D. aequipinnatus) as a model of cardiac remodeling and regeneration.

Authors:  Pascal J Lafontant; Alan R Burns; Jamie A Grivas; Mary A Lesch; Tanmoy D Lala; Sean P Reuter; Loren J Field; Tyler D Frounfelter
Journal:  Anat Rec (Hoboken)       Date:  2011-11-18       Impact factor: 2.064

6.  Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.

Authors:  David A Brown; Sharon L Hale; Christopher P Baines; Carlos L del Rio; Robert L Hamlin; Yukie Yueyama; Anusak Kijtawornrat; Steve T Yeh; Chad R Frasier; Luke M Stewart; Fatiha Moukdar; Saame Raza Shaikh; Kelsey H Fisher-Wellman; P Darrell Neufer; Robert A Kloner
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-11-28       Impact factor: 2.457

Review 7.  Oxygen-derived free radicals and myocardial reperfusion injury: an overview.

Authors:  R Bolli
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

8.  Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress.

Authors:  Maram K Reddy; Li Wu; Wei Kou; Anuja Ghorpade; Vinod Labhasetwar
Journal:  Appl Biochem Biotechnol       Date:  2008-05-29       Impact factor: 2.926

Review 9.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

10.  Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.

Authors:  Robert A Kloner; Sharon L Hale; Wangde Dai; Robert C Gorman; Takashi Shuto; Kevin J Koomalsingh; Joseph H Gorman; Ruben C Sloan; Chad R Frasier; Corinne A Watson; Phillip A Bostian; Alan P Kypson; David A Brown
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.